gliclazide has been researched along with Dermatitis Exfoliativa in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erythroderma is generalized exfoliative dermatitis, which involves more than 90% of the patient's skin." | 1.40 | Erythroderma secondary to gliclazide: a case report. ( Kacar, SD; Karaca, S; Ozuguz, P; Ozuguz, U; Tokyol, C, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozuguz, P | 1 |
| Kacar, SD | 1 |
| Ozuguz, U | 1 |
| Karaca, S | 1 |
| Tokyol, C | 1 |
1 other study available for gliclazide and Dermatitis Exfoliativa
| Article | Year |
|---|---|
Erythroderma secondary to gliclazide: a case report.
Topics: Aged; Dermatitis, Exfoliative; Drug Eruptions; Female; Gliclazide; Humans; Hyperglycemia; Hypoglycem | 2014 |